SCHEMBL7785356

SCHEMBL7785356

NC(=Nc1ccccc1)SCc1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.67
CYP3A4 P08684 1/20 0.67
CYP2D6 P10635 1/20 0.67
CYP2C19 P33261 1/20 0.67
NOS1 P29475 11/20 0.65
NOS3 P29474 10/20 0.65
NOS2 P35228 8/20 0.65
GAA P10253 1/20 0.59
TAAR1 Q96RJ0 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
IDO1 P14902 3/20 0.57
ALDH1A1 P00352 1/20 0.51
SLC22A2 O15244 2/20 0.48
HTR3E A5X5Y0 1/20 0.48
SLC22A1 O15245 1/20 0.48
SLC22A3 O75751 1/20 0.48
HTR3B O95264 1/20 0.48
PLAU P00749 1/20 0.48
HTR3A P46098 1/20 0.48
HTR3D Q70Z44 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14501379 0.96 CYP1A2 (0.62) CYP1A2CYP3A4CYP2D6CYP2C19NOS1
SCHEMBL7968255 0.84 NOS1 (0.64) CYP1A2CYP3A4CYP2D6CYP2C19NOS1
SCHEMBL10480371 0.80 TAAR1 (0.62) CYP1A2CYP3A4CYP2D6CYP2C19NOS1
SCHEMBL1387776 0.78 NOS1 (1.00) NOS1NOS3NOS2
SCHEMBL21067846 0.78 NOS1 (1.00) NOS1NOS3NOS2
SCHEMBL11064825 0.78 TAAR1 (0.66) CYP1A2CYP3A4CYP2D6CYP2C19NOS1
SCHEMBL15962333 0.78 IDO1 (0.64) CYP1A2CYP3A4CYP2D6CYP2C19NOS1
Bromide SCHEMBL11804676 0.77 NOS1 (0.96) NOS1NOS3NOS2
Iodide SCHEMBL11683524 0.77 NOS1 (1.00) NOS1NOS3NOS2
Benzylamidinoisothiourea SCHEMBL14049927 0.77 IDO1 (0.62) CYP1A2CYP3A4CYP2D6CYP2C19NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010034342-A1 Substituted urea and isothiourea derivatives as no synthase inhibitors OPLINGER JEFFREY ALAN (US) 2001-10-25 US disclosed
US-6225305-B1 Substituted urea and isothiorea derivatives as no synthase inhibitors GLAXO WELLCOME INC. 2001-05-01 US disclosed
US-6090846-A ADMINISTERING S-ETHYL-N-((4-TRIFLUOROMETHYL)PHENYL)ISOTHIOUREA GLAXO WELLCOME INC. (US) 2000-07-18 US disclosed
EP-0723438-A1 SUBSTITUTED UREA AND ISOTHIOUREA DERIVATIVES AS NO SYNTHASE INHIBITORS THE WELLCOME FOUNDATION LIMITED (GB) 1996-07-31 EP disclosed
WO-1995009619-A2 SUBSTITUTED UREA AND ISOTHIOUREA DERIVATIVES AS NO SYNTHASE INHIBITORS THE WELLCOME FOUNDATION LIMITED (GB) 1995-04-13 WO disclosed
US-4475942-A N-Phosphonomethylglycine derivatives and herbicidal compositions containing them GESHURI LABORATORIES LTD. (IL) 1984-10-09 US disclosed
EP-0103055-A1 N-phosphonomethylglycine derivatives and herbicidal compositions containing them Geshuri Laboratories Ltd. (IL) 1984-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010034342-A1 Substituted urea and isothiourea derivatives as no synthase inhibitors NOS1, NOS2, SLC14A1 CYP1A2 641/4885CYP3A4 215/4885CYP2D6 1041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.